Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MIRROR-DM: Imeglimin vs. Metformin in Newly Diagnosed Type 2 Diabetes
NCT07436182Phase 4Not yet recruiting
- Sponsor
- Mansoura University
- Start
- Mar 2026
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of imeglimin in type 2 diabetes mellitus (T2DM), sponsored by Mansoura University. Planned start Mar 2026; status: not yet recruiting.
02
Drugs
imeglimin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT07436182.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07436182.